Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture

Bioconjugate Chemistry

Volumn 8, Issue 5, 1997, Pages 708-713

  Francisco, Joseph A ^a   Gawlak, Susan L ^a   Miller, Michael ^b   Bathe, Jessie ^b   Russell, David ^b   Chace, Dana ^a   Mixan, Bruce ^a   Zhao, Lei ^a   Fell, H Perry ^a   Siegall, Clay B ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Agracetus Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CHAINS; ESCHERICHIA COLI; PLANTS (BOTANY); RECOMBINANT PROTEINS; TISSUE; TISSUE CULTURE;

ACTIVE PROTEINS; BACTERIAL TOXIN; IMMUNOTOXINS; INCLUSION BODIES; INHIBITION ACTIVITY; PROTEIN SYNTHESIS; REFOLDING; RIBOSOME-INACTIVATING PROTEIN; SINGLE CHAINS; TOBACCO CELLS;

TOBACCO;

ANIMALIA; BACTERIA (MICROORGANISMS); BRYONIA DIOICA; ESCHERICHIA COLI; NICOTIANA TABACUM; RODENTIA;

EID: 0031239836     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970107k     Document Type: Article

References (28)

1. Vitetta, E. S., Thorpe, P. E., and Uhr, J. W. (1993) Immunotoxins: magic bullets or misguided missiles? Immunol. Today 14, 252-259.
2. Siegall, C. B., Wolff, E. A., Gawlak, S. L., Paul, L., Chace, D., and Mixan, B. (1995) Immunotoxins as cancer chemotherapeutic agents. Drug Dev. Res. 34, 210-219.
3. Pastan, I., Pai, L. H., Brinkmann, U., and FitzGerald, D. (1996) Recombinant immunotoxins. Breast Cancer Res. Treat. 38, 3-9.
4. Press, O. W. (1991) Immunotoxins. Biotherapy 3, 65-76.
5. Siegall, C. B., Gawlak, S. L., Chace, D., Wolff, E. A., Mixan, B., and Marquardt, H. (1994) Characterization of ribosome-inactivating proteins isolated from Bryonia dioica and their utility as carcinoma-reactive immunoconjugates. Bioconjugate Chem. 5, 423-429.
6. Gawlak, S. L., Neubauer, M., Klei, H. E., Chang, C. Y., Einspahr, H. M., and Siegall, C. B. (1997) Molecular, biological, and preliminary structural analysis of bryodin 1, a ribosome-inactivating protein from the plant Bryonia dioica. Biochemistry 36, 3095-3103.
7. Vitetta, E. S., Stone, M., Amlot, P., Fay, J., May, R., Till, M., Newman, J., Clark, P., Collins, R., Cunningham, D., Ghetie, V., Uhr, J. W., and Thorpe, P. E. (1991) Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res. 51, 4052-4058.
8. Amlot, P. L., Stone, M. J., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V., Ramilo, O., Thorpe, P. E., Uhr, J. W., and Vitetta, E. S. (1993) A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood 82, 2624-2633.
9. Sausville, E. A., Headlee, D., Stetler-Stevenson, M., Jaffe, E. S., Solomon, D., Frigg, W. D., Herdt, J., Kopp, W. C., Rager, H., Steinberg, S. M., Ghetie, V., Schindler, J., Uhr, J., Wittes, R. E., and Vitetta, E. S. (1995) Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study. Blood 85, 3457-3465.
10. Pai, L. H., Wittes, R., Setser, A., Willingham, M. C., and Pastan, I. (1996) Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med. (N.Y.) 2, 350-353.
11. LeMaistre, C. F., Craig, F. E., Meneghetti, C., McMullin, B., Parker, K., Reuben, J., Boldt, D. H., Rosenblum, M., and Woodworth, T. (1993) Phase I trial of a 90-minute infusion f the fusion toxin DAB486IL-2 in hematological cancers. Cancer Res. 53, 3930-3934.
12. Gardner, R. C., Howarth, A. J., Hahn, P., Brown-Luedi, M., Shepherd, R. J., and Messing, J. (1981) The complete nucleotide sequence of an infectious clone of cauliflower mosaic virus by M13mp7 shotgun sequencing. Nucleic Acids Res. 9, 2871-2888.
13. DeLoose, M., Gheysen, G., Tire, C., Gielen, J., Villarroel, R., Gentello, C., Van Montagu, M., Depicker, A., and Inze, D. (1991) The extensin signal peptide allows secretion of a heterologous protein from protoplasts. Gene 99, 95-100.
14. Depicker, A., Stachel, S., Dhaese, P., Zambryski, P., and Goodman, H. M. (1982) Nopaline synthase: transcript mapping and DNA sequence. J. Mol. Appl. Genet. 1, 561-573.
15. Francisco, J. A., Gawlak, S. L., and Siegall, C. B. (1997) Construction, expression and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein Bryodin 1. J. Biol. Chem. (in press).
16. Bubeck, P., Winkler, M., and Bautsch, W. (1993) Rapid cloning by homologous recombination in vivo. Nucleic Acids Res. 21, 3601-3602.
17. McCabe, D. E., Swain, W. F., Martinell, B. J., and Christou, P. (1988) Stable transformation of soybean (Glycine max) by particle acceleration. BioTechnology 6, 923-926.
18. Francisco, J. A., Gilliland, L. K., Stebbins, M. R., Norris, N. A., Ledbetter, J. A., and Siegall, C. B. (1995) Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen. Cancer Res. 55, 3099-3104.
19. Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A. (1992) A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. U.S.A. 89, 6550-6554.
20. Endo, Y., Mitsui, K, Motizuki, M., and Tsurugi, K. (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes: the site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins. J. Biol. Chem. 262, 5908-5912.
21. Battelli, M. G., Montacuti, V., and Stirpe, F. (1992) High sensitivity of cultured human trophoblasts to ribosome-inactivating proteins. Exp. Cell Res. 201, 109-112.
22. Conry, R. M., Khazaeli, M. B., Saleh, M. N., Ghetie, V., Vitetta, E. S., Liu, T., and LoBuglio, A. F. (1996) Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration. J. Immunother. 18, 231-241.
23. Siegall, C. B., Liggitt, D., Chace, D., Tepper, M. A., and Fell, H. P. (1994) Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity. Proc. Natl. Acad. Sci. U.S.A. 91, 9514-9518.
24. Siegall, C. B., Liggitt, D., Chace, D., Mixan, B., Sugai, J., Davidson, T., and Steinitz, M. (1997) Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs. Clin. Cancer Res. 3, 339-345.
25. Clark, E. A., and Ledbetter, J. A. (1986) Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. U.S.A. 83, 4494-4498.
26. Francisco, J. A., Schreiber, G. J., Comereski, C. R., Mezza, L. E., Warner, G. L., Davidson, T. J., Ledbetter, J. A., and Siegall, C. B. (1997) In vivo efficacy and toxicity of a single-chain immunotoxin targeted to CD40. Blood 89, 4493-4500.
27. Schodin, B. A., and Kranz, D. M. (1993) Binding affinity and inhibitory properties of a single-chain anti-T cell receptor antibody. J. Biol. Chem. 268, 25722-25727.
28. Griffiths, A. D., Malmqvist, M., Marks, J. D., Bye, J. M., Embleton, M. J., McCafferty, J., Maier, M., Holliger, K. P., Gorick, B. D., Hughes-Jones, N. C., Hoogenboom, H. R., and Winter, G. (1993) Human anti-self antibodies with high specificity from phage display libraries. EMBO J. 12, 725-734.